MedPath
FDA Approval

Xenon

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 28, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Xenon-133(20 mCi in 1 1)

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Lantheus Medical Imaging, Inc.

Lantheus Medical Imaging, Inc.

176786812

Institut National des Radioelements

Lantheus Medical Imaging, Inc.

283049187

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Xenon

Product Details

NDC Product Code
11994-128
Application Number
NDA017284
Marketing Category
NDA (C73594)
Route of Administration
RESPIRATORY (INHALATION)
Effective Date
November 28, 2022
Xenon-133Active
Code: X3P9A5HNYFClass: ACTIBQuantity: 20 mCi in 1 1
CARBON DIOXIDEInactive
Code: 142M471B3JClass: IACT

Xenon

Product Details

NDC Product Code
11994-127
Application Number
NDA017284
Marketing Category
NDA (C73594)
Route of Administration
RESPIRATORY (INHALATION)
Effective Date
November 28, 2022
Xenon-133Active
Code: X3P9A5HNYFClass: ACTIBQuantity: 10 mCi in 1 1
CARBON DIOXIDEInactive
Code: 142M471B3JClass: IACT
© Copyright 2025. All Rights Reserved by MedPath